HIGH POINT , NC — Banner Pharmacaps Inc., a leader in the development and manufacture of nutritional supplements, prescription and over-the-counter pharmaceuticals announced today the issuance of U.S. Patent No. 6,482,516 pertaining to Banner’s Soflet ® dosage form.
This latest patent awards Banner a number of claims related to the tamper-evident dosage form. Most notably, the patent covers the enrobed product’s physical properties and the utilization of gelatin or other suitable materials being applied to the core. This patent broadly protects the end product, and does not include claims directed to a method of manufacture or equipment used in the processing. “This is a significant expansion of our patent rights,” said Dr. Roger Gordon, President - U.S. Operations of Banner Pharmacaps Inc. “We have always believed that Soflet ® Gelcaps should have full product patent coverage, and we are pleased that the United States Patent Office has recognized the ingenuity and novelty of our Soflet ® technology and products,” said Dr. Gordon.
The latest Banner patent joins the Banner family of worldwide Soflet ® patents that already protects the Soflet ® processes and machinery. Banner is pleased that numerous countries have decided that protection to the enrobed product, methods, and apparatus is warranted. “Offering our customers these patented and proprietary products further strengthens our position as a leader in drug development and innovation,” said Dr. Gordon.
Soflet ® Gelcaps are a dosage form preferred by consumers because of the ease of swallowing and the taste and odor masking properties imparted by the gelatin coating. Studies also show that consumers prefer the appearance of Soflet ® Gelcap products vs. tablets. Because of the strong consumer preference related to this dosage form, as well as the brand-building possibilities associated with a patented product, nutritional companies are recognizing the market possibilities that accompany this technology. It is ideal for odorous and hard-to-swallow supplements like multivitamins and women’s healthcare supplements. Soflet ® Gelcap technology is already widely used in over-the-counter analgesics, both branded and private label.
Banner Pharmacaps Inc. is a global leader in drug delivery technology and proprietary healthcare products including softgels and Soflet® Gelcaps. Banner Pharmacaps represents a dynamic, innovative company drawing on 130 years of collective experience. Founded in 1994 with the merger of Banner Gelatin Products Corp. and Pharmacaps Inc., and the subsequent acquisition of Chase Pharmaceutical, the organization complements the global mission of its Dutch parent, Sobel NV, with operations throughout Europe, Asia, and North America and Mexico .